75
Views
16
CrossRef citations to date
0
Altmetric
Original Articles

Prospective, Open-Label Comparative Study of Liver Toxicity in an Unselected Population of HIV-Infected Patients Treated for the First Time with Efavirenz or Nevirapine

, &
Pages 302-311 | Published online: 02 Feb 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

S Hyder Hussaini & Elizabeth A Farrington. (2007) Idiosyncratic drug-induced liver injury: an overview. Expert Opinion on Drug Safety 6:6, pages 673-684.
Read now
Saskia ME Vrouenraets, Ferdinand WNM Wit, Jacqueline van Tongeren & Joep MA Lange. (2007) Efavirenz: a review. Expert Opinion on Pharmacotherapy 8:6, pages 851-871.
Read now

Articles from other publishers (14)

Kiamu Kurosawa, Masataka Nakano, Itsuki Yokoseki, Mai Nagaoka, Seiya Takemoto, Yoshiyuki Sakai, Kaoru Kobayashi, Yasuhiro Kazuki, Tatsuki Fukami & Miki Nakajima. (2023) ncBAF enhances PXR-mediated transcriptional activation in the human and mouse liver. Biochemical Pharmacology 215, pages 115733.
Crossref
Kellie J. Goodlet, Monika T. Zmarlicka & Alyssa M. Peckham. (2018) Drug–drug interactions and clinical considerations with co-administration of antiretrovirals and psychotropic drugs. CNS Spectrums 24:03, pages 287-312.
Crossref
Lawrence Mbuagbaw, Sara Mursleen, James H Irlam, Alicen B Spaulding, George W Rutherford & Nandi Siegfried. (2016) Efavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals. Cochrane Database of Systematic Reviews 2016:12.
Crossref
C. Padmapriyadarsini, P.K. Bhavani, Alice Tang, Hemanth Kumar, C. Ponnuraja, G. Narendran, Elizabeth Hannah, C. Ramesh, C. Chandrasekar, Christine Wanke & Soumya Swaminathan. (2013) Early changes in hepatic function among HIV–tuberculosis patients treated with nevirapine or efavirenz along with rifampin-based anti-tuberculosis therapy. International Journal of Infectious Diseases 17:12, pages e1154-e1159.
Crossref
Ignacio A. EcheniqueJosiah D. Rich. (2013) EFV/FTC/TDF-Associated Hepatotoxicity: A Case Report and Review. AIDS Patient Care and STDs 27:9, pages 493-497.
Crossref
P-M Girard, TB Campbell, B Grinsztejn, J Hartikainen, A Rachline, S Nijs & J Witek. (2012) Pooled week 96 results of the phase III DUET-1 and DUET-2 trials of etravirine: further analysis of adverse events and laboratory abnormalities of special interest. HIV Medicine 13:7, pages 427-435.
Crossref
Feng Zhou, Gerald F Kominski, Han-Zhu Qian, Jiansheng Wang, Song Duan, Zhiwei Guo & Xinping Zhao. (2011) Expenditures for the care of HIV-infected patients in rural areas in China's antiretroviral therapy programs. BMC Medicine 9:1.
Crossref
Lawrence CE Mbuagbaw, James H Irlam, Alicen Spaulding, George W Rutherford & Nandi Siegfried. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Beatriz GrinsztejnGiovanni Di PerriWilliam TownerBrian WoodfallGoedele De SmedtMonika Peeters. (2010) A Review of the Safety and Tolerability Profile of the Next-Generation NNRTI Etravirine. AIDS Research and Human Retroviruses 26:7, pages 725-733.
Crossref
Paul J. WeidleDavid MooreJonathan MerminKate BuchaczWilly WereRobert DowningAminah KigoziVincent NdazimaPhilip PetersJohn T. Brooks. (2008) Liver Enzymes Improve Over Twenty-Four Months of First-Line Non-Nucleoside Reverse Transcriptase Inhibitor-Based Therapy in Rural Uganda. AIDS Patient Care and STDs 22:10, pages 787-795.
Crossref
Roberto Manfredi & Leonardo Calza. (2007) Safety Issues About Nevirapine Administration in HIV-Infected Pregnant Women. JAIDS Journal of Acquired Immune Deficiency Syndromes 45:3, pages 365-368.
Crossref
Carlo Torti, Silvia Costarelli, Annalisa De Silvestri, Eugenia Quiros-Roldan, Giuseppe Lapadula, Giuliana Cologni, Giuseppe Paraninfo, Filippo Castelnuovo, Massimo Puoti & Giampiero Carosi. (2007) Analysis of Severe Hepatic Events Associated with Nevirapine-Containing Regimens. Drug Safety 30:12, pages 1161-1169.
Crossref
Roberto Manfredi & Leonardo Calza. (2006) Nevirapine versus efavirenz in 742 patients: no link of liver toxicity with female sex, and a baseline CD4 cell count greater than 250 cells/μl. AIDS 20:17, pages 2233-2236.
Crossref
. (2006) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 15:8.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.